Neuralstem Reports Third Quarter 2017 Fiscal Results and Provides Clinical and Business Update
GERMANTOWN, Md., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (NASDAQ:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, reported its financial results for the three and …